#ThinkSabio US Market Morning Brief
Pre-Market Gainers:
$TBIO + 185% : Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market (Sep 10)
$ZEO +155%
$XCUR +145% : Exicure, Inc. Receives Extension from Nasdaq Hearings Panel (Sep 18)
$ACHL +45% : Achilles Therapeutics Announces Strategic Update Achilles to discontinue development of TIL-based cNeT therapy
$EWTX +33% : Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)

Pre-Market Decliners:
$EFSH -25% : 1847 Reports Second Quarter 2024 Financial Results and Provides Business Update(19 AUG)
$PGNY - 23% PGNY: JMP Securities Downgrades to Market Perform from Market Outperform
$SGC -19%
Pre-Market Penny Gainers:
$SGN +92% : Signing Day Sports Signs Binding Term Sheet to Acquire Majority Equity Interest in High Growth Sports Gaming Technology Company Swifty Global
$VERO +66% : Venus Concept Announces Australian Regulatory Approval for Venus Bliss MAX
$FRGT +33% : Freight Technologies Secures Win with Bayer(11 SEP)
Headlines:
$CRWD : Focused on the path to $10B ARR; Positioned to emerge even stronger post-July 19 outage; Pipeline generation returning to pre-incident levels - investor slides (CrowdStrike Holdings Inc)
$ACHL : Achilles Therapeutics Announces Strategic Update Achilles to discontinue development of TIL-based cNeT therapy
$VNDA : FDA issues CRL for Tradipitant NDA.